Sherry Fu

1.6k total citations
21 papers, 1.2k citations indexed

About

Sherry Fu is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Sherry Fu has authored 21 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Hepatology and 9 papers in Immunology. Recurrent topics in Sherry Fu's work include Hepatitis C virus research (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis B Virus Studies (7 papers). Sherry Fu is often cited by papers focused on Hepatitis C virus research (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Hepatitis B Virus Studies (7 papers). Sherry Fu collaborates with scholars based in United States, China and Germany. Sherry Fu's co-authors include Jorge A. Marrero, Anna S. Lok, Robert J. Fontana, Grace L. Su, Hari S. Conjeevaram, Amit G. Singal, Michael L. Volk, Yang‐Xin Fu, Liufu Deng and Fred Askari and has published in prestigious journals such as Journal of Clinical Oncology, Nature Immunology and The Journal of Immunology.

In The Last Decade

Sherry Fu

21 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sherry Fu United States 15 708 620 267 172 164 21 1.2k
Goki Suda Japan 19 433 0.6× 475 0.8× 332 1.2× 140 0.8× 86 0.5× 71 1.0k
Ethan M. Weinberg United States 20 605 0.9× 570 0.9× 415 1.6× 154 0.9× 85 0.5× 51 1.5k
Motohiko Tanaka Japan 15 1.2k 1.7× 1.4k 2.2× 197 0.7× 194 1.1× 102 0.6× 49 1.8k
Takuya Sho Japan 16 381 0.5× 427 0.7× 193 0.7× 110 0.6× 66 0.4× 52 765
Tetsuya Ichijo Japan 22 1.1k 1.6× 1.1k 1.8× 136 0.5× 115 0.7× 109 0.7× 45 1.6k
S. Nishiguchi Japan 18 1.3k 1.8× 1.4k 2.2× 292 1.1× 185 1.1× 58 0.4× 35 1.9k
Carmela Cursaro Italy 25 1.4k 2.0× 1.6k 2.5× 184 0.7× 214 1.2× 195 1.2× 95 2.1k
Shuhei Hige Japan 21 1.4k 2.0× 1.5k 2.4× 208 0.8× 121 0.7× 187 1.1× 66 2.0k
Rafael Quadri Switzerland 19 954 1.3× 899 1.4× 191 0.7× 92 0.5× 171 1.0× 35 1.5k
Ono S Brazil 21 1.2k 1.7× 1.2k 2.0× 219 0.8× 117 0.7× 104 0.6× 101 1.7k

Countries citing papers authored by Sherry Fu

Since Specialization
Citations

This map shows the geographic impact of Sherry Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Fu more than expected).

Fields of papers citing papers by Sherry Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherry Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Fu. The network helps show where Sherry Fu may publish in the future.

Co-authorship network of co-authors of Sherry Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Sherry Fu. A scholar is included among the top collaborators of Sherry Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry Fu. Sherry Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bugno, Jason, Liangliang Wang, Xianbin Yu, et al.. (2024). Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance. Clinical Cancer Research. 30(19). 4450–4463. 3 indexed citations
2.
Fu, Sherry, David E. Gerber, & Muhammad Shaalan Beg. (2022). Decentralized Clinical Trials in Oncology: Are We Ready for a Virtual-First Paradigm?. Journal of Clinical Oncology. 41(2). 181–185. 16 indexed citations
3.
4.
Wang, Yang, Juanjuan Zhao, Zhichen Sun, et al.. (2020). Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice. UNC Libraries. 1 indexed citations
5.
Yang, Ming, Huiying Rao, Sherry Fu, et al.. (2017). Temporal Changes in the Modes of Hepatitis C Virus Transmission in the USA and Northern China. Digestive Diseases and Sciences. 62(8). 2141–2149. 4 indexed citations
6.
Bian, Yingjie, Zheng Zhang, Zhichen Sun, et al.. (2017). Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice. Hepatology. 66(4). 1067–1082. 45 indexed citations
7.
Parikh, Neehar D., Sherry Fu, Huiying Rao, et al.. (2017). Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA. Digestive Diseases and Sciences. 62(11). 3243–3253. 15 indexed citations
8.
Fu, Sherry, Ming Yang, Bo Feng, et al.. (2017). The higher prevalence of truncal obesity and diabetes in American than Chinese patients with chronic hepatitis C might contribute to more rapid progression to advanced liver disease. Alimentary Pharmacology & Therapeutics. 46(8). 731–740. 21 indexed citations
9.
Liu, Longchao, Dan Yang, Sherry Fu, et al.. (2016). Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination. The Journal of Immunology. 196(7). 3079–3087. 66 indexed citations
10.
Wang, Tianyi, Xisui Chen, Zhe Guan, et al.. (2015). A Comparative Study of Patients’ Attitudes Toward Clinical Research in the United States and Urban and Rural China. Clinical and Translational Science. 8(2). 123–131. 10 indexed citations
11.
Deng, Liufu, Hua Liang, Sherry Fu, Ralph R. Weichselbaum, & Yang‐Xin Fu. (2015). From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation Therapy. Clinical Cancer Research. 22(1). 20–25. 71 indexed citations
12.
Chen, Xisui, Zhe Guan, Huiying Rao, et al.. (2014). A comparative study of patients’ knowledge about hepatitis C in the United States and in urban and rural China. Hepatology International. 9(1). 58–66. 15 indexed citations
13.
Salgia, Reena, Amit G. Singal, Sherry Fu, Shawn J. Pelletier, & Jorge A. Marrero. (2013). Improved Post-Transplant Survival in the United States for Patients with Cholangiocarcinoma After 2000. Digestive Diseases and Sciences. 59(5). 1048–1054. 22 indexed citations
14.
Upadhyay, Vaibhav, Valeriy Poroyko, Tae-Jin Kim, et al.. (2012). Lymphotoxin regulates commensal responses to enable diet-induced obesity. Nature Immunology. 13(10). 947–953. 108 indexed citations
15.
Singal, Amit G., Hari S. Conjeevaram, Michael L. Volk, et al.. (2012). Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis. Cancer Epidemiology Biomarkers & Prevention. 21(5). 793–799. 196 indexed citations
16.
Welling, Theodore H., Sherry Fu, Shanshan Wan, Weiping Zou, & Jorge A. Marrero. (2012). Elevated Serum IL-8 Is Associated with the Presence of Hepatocellular Carcinoma and Independently Predicts Survival. Cancer Investigation. 30(10). 689–697. 24 indexed citations
17.
Singal, Amit G., Michael L. Volk, Mina O. Rakoski, et al.. (2011). Patient Involvement in Healthcare is Associated With Higher Rates of Surveillance for Hepatocellular Carcinoma. Journal of Clinical Gastroenterology. 45(8). 727–732. 74 indexed citations
18.
Salgia, Reena, Amit G. Singal, Sherry Fu, Shawn J. Pelletier, & Jorge A. Marrero. (2011). Improved Post-Transplant Survival in the United States for Patients With Cholangiocarcinoma After 2000. Gastroenterology. 140(5). S–912. 2 indexed citations
19.
Pelletier, Shawn J., Sherry Fu, Veena Thyagarajan, et al.. (2009). An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transplantation. 15(8). 859–868. 108 indexed citations
20.
Marrero, Jorge A., Robert J. Fontana, Sherry Fu, et al.. (2004). Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. Journal of Hepatology. 42(2). 218–224. 356 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Goki Suda Breakdown of academic impact, for papers by Ethan M. Weinberg Breakdown of academic impact, for papers by Motohiko Tanaka Breakdown of academic impact, for papers by Takuya Sho Breakdown of academic impact, for papers by Tetsuya Ichijo Breakdown of academic impact, for papers by S. Nishiguchi Breakdown of academic impact, for papers by Carmela Cursaro Breakdown of academic impact, for papers by Shuhei Hige Breakdown of academic impact, for papers by Rafael Quadri Breakdown of academic impact, for papers by Ono S
Rankless by CCL
2026